Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort - PubMed
4 hours ago
- #radiation-therapy
- #oligometastatic-prostate-cancer
- #psma-pet-ct
- Primary outcomes include biochemical recurrence-free survival (BRFS) and overall survival (OS) after inverse probability of treatment weighting.
- PSMA PET/CT guidance showed longer BRFS compared to choline PET/CT (median not reached vs. 11.7 months) and conventional imaging (not reached vs. 7.1 months).
- Overall survival favored PSMA PET/CT over conventional imaging (median not reached vs. 46.0 months).
- The study supports the therapeutic relevance of PSMA PET/CT for planning metastasis-directed therapy in omCRPC.